FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Hanfelt

Research Profile

Disorders

Living Beings

Chemicals & Drugs

Concepts & Ideas

Physiology

Transfection

Activities & Behaviors

Clinical Trials, Phase II as Topic

Co-author Network

Publications

TOP 3
Cecilia Prudente; J Xiao; John Hanfelt; Ellen J Hess; M S Ledoux; CARLOS PARDO-VILLAMIZAR; Hyder A Jinnah
Neuropathology of cervical dystonia.
Felicia Goldstein; Angela V Ashley; Yohannes W Endeshaw; John Hanfelt; James J Lah; Allan Levey
Effects of hypertension and hypercholesterolemia on cognitive functioning in patients with alzheimer disease.
S B Crawford; John Hanfelt
Testing for the presence of multiple sources of informative dropout in longitudinal data.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Hanfelt (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Cecilia Prudente; J Xiao; John Hanfelt; Ellen J Hess; M S Ledoux; CARLOS PARDO-VILLAMIZAR; Hyder A Jinnah
Neuropathology of cervical dystonia.
Experimental neurology 2013;241():95-104.
2008: Felicia Goldstein; Angela V Ashley; Yohannes W Endeshaw; John Hanfelt; James J Lah; Allan Levey
Effects of hypertension and hypercholesterolemia on cognitive functioning in patients with alzheimer disease.
Alzheimer disease and associated disorders 2008;22(4):336-42.
2008: S B Crawford; John Hanfelt
Testing for the presence of multiple sources of informative dropout in longitudinal data.
Statistics in medicine 2008;27(21):4175-89.
2008: Nicholas T Seyfried; Ping Xu; Duc M Duong; Dongmei Cheng; John Hanfelt; Junmin Peng
Systematic approach for validating the ubiquitinated proteome.
Analytical chemistry 2008;80(11):4161-9.
2007: Jian-Ying Zhou; John Hanfelt; Junmin Peng
Clinical proteomics in neurodegenerative diseases.
Proteomics. Clinical applications 2007;1(11):1342-50.
2007: Ami R Rosen; Nelson STEENLAND; John Hanfelt; Stewart A Factor; James J Lah; Allan Levey
Evidence of shared risk for Alzheimer's disease and Parkinson's disease using family history.
Neurogenetics 2007;8(4):263-70.
2006: Dongmei Cheng; Casper C Hoogenraad; John Rush; Elizabeth Ramm; Max A Schlager; Duc M Duong; Ping Xu; Sameera R Wijayawardana; John Hanfelt; Terunaga Nakagawa; Morgan Sheng; Junmin Peng
Relative and absolute quantification of postsynaptic density proteome isolated from rat forebrain and cerebellum.
Molecular & cellular proteomics : MCP 2006;5(6):1158-70.
2005: Felicia Goldstein; A V Ashley; LJ Freedman; L Penix; James J Lah; John Hanfelt; Allan Levey
Hypertension and cognitive performance in African Americans with Alzheimer disease.
Neurology 2005;64(5):899-901.
2004: John L Marshall; Steven G Eisenberg; Michael Johnson; John Hanfelt; F Andrew Dorr; Dorraya El-Ashry; Michael D Oberst; Yair Fuxman; Jon T Holmlund; Shakun Malik
A phase II trial of ISIS 3521 in patients with metastatic colorectal cancer.
Clinical colorectal cancer 2004;4(4):268-74.
2004: Michael S Okun; Mahlon R DeLong; John Hanfelt; Marla Gearing; Allan Levey
Plasma testosterone levels in Alzheimer and Parkinson diseases.
Neurology 2004;62(3):411-3.
2004: Michael S Okun; G P Crucian; L Fischer; Benjamin L Walter; C M Testa; Jerrold L Vitek; Mahlon R DeLong; John Hanfelt; Xuemei Huang
Testosterone deficiency in a Parkinson's disease clinic: results of a survey.
Journal of neurology, neurosurgery, and psychiatry 2004;75(1):165-6.
2001: Felicia Goldstein; A V Ashley; Marla Gearing; John Hanfelt; L Penix; LJ Freedman; Allan Levey
Apolipoprotein E and age at onset of Alzheimer's disease in African American patients.
Neurology 2001;57(10):1923-5.
2001: Pankaj Bhargava; John L Marshall; K Fried; M Williams; P Lefebvre; William Dahut; John Hanfelt; Edmund Gehan; Manuela Figuera; Michael J Hawkins; Naiyer A Rizvi
Phase I and pharmacokinetic study of two sequences of gemcitabine and docetaxel administered weekly to patients with advanced cancer.
Cancer chemotherapy and pharmacology 2001;48(2):95-103.
2000: Pankaj Bhargava; Glenn Eisen; D A Holterman; Norio Azumi; Dan-Paul Hartmann; John Hanfelt; Stanley B Benjamin; Marc Lippman; Elizabeth Montgomery
Endoscopic mapping and surrogate markers for better surveillance in Barrett esophagus. A study of 700 biopsy specimens.
American journal of clinical pathology 2000;114(4):552-63.
2000: Said Baidas; Eric P Winer; G F Fleming; L Harris; J M Pluda; J G Crawford; H Yamauchi; Claudine Isaacs; John Hanfelt; Mariella Tefft; David A Flockhart; M D Johnson; Michael J Hawkins; Marc Lippman; Daniel F Hayes
Phase II evaluation of thalidomide in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(14):2710-7.
2000: Vered Stearns; Claudine Isaacs; J Rowland; J Crawford; M J Ellis; R Kramer; William Lawrence; John Hanfelt; Daniel F Hayes
A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(1):17-22.
1999: John Hanfelt; R S Slack; Edmund Gehan
A modification of Simon's optimal design for phase II trials when the criterion is median sample size.
Controlled clinical trials 1999;20(6):555-66.
1999: John Hanfelt
Optimal multi-stage designs for a phase II trial that permits one dose escalation.
Statistics in medicine 1999;18(11):1323-39.
1998: Sandra W McLeskey; Christopher Tobias; PR Vezza; A C Filie; FG Kern; John Hanfelt
Tumor growth of FGF or VEGF transfected MCF-7 breast carcinoma cells correlates with density of specific microvessels independent of the transfected angiogenic factor.
The American journal of pathology 1998;153(6):1993-2006.
1998: John Hanfelt; Kung-Yee Liang
Inference for odds ratio regression models with sparse dependent data.
Biometrics 1998;54(1):136-47.
1998: Lurong Zhang; S Kharbanda; John Hanfelt; FG Kern
Both autocrine and paracrine effects of transfected acidic fibroblast growth factor are involved in the estrogen-independent and antiestrogen-resistant growth of MCF-7 breast cancer cells.
Cancer research 1998;58(2):352-61.
1998: Matthew J Ellis; S Jenkins; John Hanfelt; M E Redington; M Taylor; R Leek; K Siddle; A Harris
Insulin-like growth factors in human breast cancer.
Breast cancer research and treatment 1998;52(1-3):175-84.
1997: John L Marshall; Anton Wellstein; James M Rae; R J DeLap; K Phipps; John Hanfelt; MK Yunmbam; J X Sun; K L Duchin; Michael J Hawkins
Phase I trial of orally administered pentosan polysulfate in patients with advanced cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(12 Pt 1):2347-54.
1997: John Hanfelt
Statistical approaches to experimental design and data analysis of in vivo studies.
Breast cancer research and treatment 1997;46(2-3):279-302.
1997: Lurong Zhang; S Kharbanda; D Chen; J Bullocks; DL Miller; Ivan Ding; John Hanfelt; Sandra W McLeskey; FG Kern
MCF-7 breast carcinoma cells overexpressing FGF-1 form vascularized, metastatic tumors in ovariectomized or tamoxifen-treated nude mice.
Oncogene 1997;15(17):2093-108.
1997: Moody D Wharam; John Hanfelt; MC Tefft; J Johnston; L G Ensign; John C. Breneman; Sarah S Donaldson; Christopher J Fryer; Edmund Gehan; R Beverly Raney; Harold M Maurer
Radiation therapy for rhabdomyosarcoma: local failure risk for Clinical Group III patients on Intergroup Rhabdomyosarcoma Study II.
International journal of radiation oncology, biology, physics 1997;38(4):797-804.
1994: Kung-Yee Liang; John Hanfelt
On the use of the quasi-likelihood method in teratological experiments.
Biometrics 1994;50(3):872-80.